Where the clone is selected: stage-specific selection from hematopoietic stem cells to plaque macrophages in clonal hematopoiesis
Clonal hematopoiesis of indeterminate potential (CHIP) raises cardiovascular risk, yet the size of a clone in blood does not by itself explain how that clone contributes to disease. We argue that selection acts not once but at three dissociable checkpoints: competition among hematopoietic stem cells, myeloid lineage...